Internship and Co-op Opportunities

Experience That Matters

We give everyone who works with us the chance to apply their expertise to real-world problems.

We enable research on disease, cures, and prevention. We help determine the safety of what we eat and drink. We provide law enforcement with 21st-century forensic tools to fight crime. We help scientists develop cleaner fuels, better therapeutics and stronger crops. Through our work around the world, we further innovation in every field that affects our lives. Our scientific ambition and global reach dare our finance, computer science and legal teams to redefine the threshold of achievement. If you’re ready to make a difference on a scale that makes sure you and your contribution matter more, we’re interested in talking with you.

You may be in a BA, MA or PhD program with a major in Biology, Chemistry, Computer Science, Chemical Engineering, Mechanical Engineering, Finance, Accounting, Marketing, Human Resources or a custom creation. You’re hungry to team up with other great people with great minds and make a positive impact on the human condition.

Intern and Co-op Opportunities

We’re ready with the right people, moments and means to help you take charge of your impact in the world. Whether you are here in the spring, summer or fall, we’ll help you advance your skills with on-the-job training, technical classes and professional development opportunities. We’ll connect you with our executives and subject matter experts through Lunch and Learn presentations and introduce you to interns from across the nation to network and work on projects together.

Ready to get started? Search for student opportunities right now.

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)